Indian Drug Company To Copy Roche Flu Drug

Law360, New York (October 14, 2005, 12:00 AM EDT) -- In the midst of a global panic over a possible bird flu pandemic, an Indian drug company has decided to produce a generic version of Roche Pharmaceuticals’ Tamiflu treatment without permission from the patent holder.

Indian drug maker Cipla said it would initiate production of the drug regardless of whether Roche grants the company a license.

"Right or wrong, we are going to commercialize and make Oseltamivir," Yusuf K. Hamied, chairman of Mumbai-based Cipla, told The New York Times. Oseltamivir is the drug’s generic name....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.